Biophysical insights into interaction mechanism of cediranib with human serum albumin: In-vitro and in-silico perspectives
{{output}}
Cediranib (CB), a tyrosine kinase inhibitor, exhibits encouraging anticancer activity against breast, prostate, glioblastoma, and non-small cell lung cancer cells. This study used multi-spectral and computational analyses to elucidate the binding mechanism of ... ...
